Surmodics reported $0 in Loan Capital for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Anika Therapeutics ANIK:US $ 0M 0M
Arrowhead Research ARWR:US $ 0 0
Baxter International BAX:US $ 5710M 29M
Bioscrip BIOS:US $ 1121.14M 6.04M
Cryolife CRY:US $ 308.05M 6.94M
Edap Tms EDAP:US $ 1.16M 0.54M
Edwards Lifesciences EW:US $ 595.4M 0.2M
Genmark Diagnostics GNMK:US $ 71.3M 0.55M
Haemonetics HAE:US $ 690.59M 397.87M
Merit Medical Systems MMSI:US $ 284.9M 27.98M
Mesa Laboratories MLAB:US $ 145.68M 1.37M
Oxford Immunotec Global OXFD:US $ 0M 0M
Providence Service PRSC:US $ 486.7M 0.72M
Stryker SYK:US $ 12734M 325M
Surmodics SRDX:US $ 0M 0M
Trinity Biotech TRIB:US $ 84.04M 15.24M